Merck’s Januvia sales top 18.8 billion won in first half

Published: 2010-07-21 06:59:00
Updated: 2010-07-21 06:59:00
The US based Merck’s Januvia has gained its momentum as its sales of its flagship model posted 18.8 billion won, up a whopping 189.2 percent from the same period of last year.

Januvia, a pill that was approved by the US Food and Drug Administration in October of 2006, lowered blood-sugar to a...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.